The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.10
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.20 (18.182%)
Open: 1.20
High: 1.20
Low: 1.20
Prev. Close: 1.20
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

12 Dec 2023 07:00

RNS Number : 4049W
Image Scan Holdings PLC
12 December 2023
 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

 

Preliminary Results for the Year Ended 30 September 2023

 

Image Scan (AIM: IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets, today announces preliminary results for the year ended 30 September 2023.

HIGHLIGHTS

 

 

FINANCIAL HEADLINES

· Order intake up 31% to £2.9m (2022: £2.2m)

· Sales up 50% to £3.0m (2022: £2.0m)

· Gross profit 48% (2022:54%)

· Costs down 5% £1.4m (2022: £1.4m)

· Pre-tax profit £0.1m (2022: loss: £0.35m)

· Year-end order book £0.65m (2022: £0.71m)

· Year-end cash balance £0.96m (2022: £0.69m)

 

Image Scan's Chief Executive, Vince Deery, commented: 

 

I'm very pleased by our results, a testament to the team's tireless efforts for a profitable year. New products and an optimised cost base significantly contributed to this turnaround. Our extended portable product range for the security market gained traction, resulting in a substantial uplift in sales compared to the previous year. With a robust operational and financial foundation, we look forward to the coming year, aiming for organic growth and strategic development. My sincere thanks to the team for their commitment in propelling us into profitability.

 

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

-ENDS-

 

Image Scan Holdings plc Tel: +44 (0) 1509 817400

Vincent Deery CEO

Sarah Atwell-King, CFO & Company Secretary

 

 

WH Ireland Limited - Nominated Advisor and Corporate Broker Tel: +44 (0) 207 220 1666

Mike Coe/Sarah Mather (Corporate Finance)

 

ABOUT IMAGE SCAN HOLDINGS PLC

About Image Scan Holdings plc

The core activity of the Group is the manufacture of portable X-ray systems for security and counter terrorism applications. The Group recently launched a cabinet X-ray machine and is replacing its Axis range of checkpoint X-ray systems with new machines developed with a partner. All these products are taken to market across the world through a strong network of international partners.

 

In addition, over the last sixteen years, Image Scan has developed and manufactured industrial X-ray inspection systems, the MDXi range. The primary market for these systems is in automotive emissions control where they are used for quality control inspection of catalytic converters and diesel particulate filters.

 

The visibility and reach of the Company's 3DX-Ray brand has been further strengthened through a new LinkedIn profile focussed on its EOD and counter-terrorism activities. This can be found at: https://www.linkedin.com/company/3dx-ray/

 

For further information on the Company, please visit: www.ish.co.uk - and for further information on its products, please visit: www.3dx-ray.com

 

CHAIRMANS STATEMENT

 

Overview

2023 delivered a welcome return to profit, meeting expectation. This was derived from strong teamwork, organisational restructuring and the return to near pre-pandemic levels of market activity.

 

Financial Summary

 

For the year ended 30 September 2023 (the "Year"), the Group generated revenues of £3.0m (2022: £2.0m), up 50% and a profit before tax of £0.1m (2022: loss £0.35m). This performance was the result of a strong recovery in sales and good cost control. There has been a significant increase in the Group cash balances to £0.96m (2022: £0.69m).

 

The launch of new products and the continued new product pipeline gives us confidence for 2024.

 

Environmental, Social and Governance

 

Image Scan recognises the importance of adopting a strong environmental, social and governance ("ESG") framework, and this guides our overarching business objectives and is influential to serving the needs of all our key stakeholders. We are confident in the robust procedures we have in place across the business and intend to continue building on these in 2024.

 

Board Composition

 

The development of the board has continued this year with the appointment of Sunil Vadgama as a Non-Executive Director in December 2022. He has an excellent technical background and understanding of the product range. Dr Richard Leaver resigned from the board in September 2023 after eight years of dedicated service. The Board extends its thanks to Richard for all he has contributed and wishes him well in his future.

 

 

Outlook

 

On behalf of the Board and the dedicated team at Image Scan, I wish to thank our colleagues and customers for their invaluable contributions throughout 2023. Their commitment has been instrumental in positioning us for the success we outline below/within this report.

 

Our trading performance, aligning with expectations, reflects a commendable 50% increase in revenue and a swing of c.£450k into profitability. This accomplishment is a testament to the diligent efforts of our restructured team and the positive shifts in the business environment.

 

With a robust balance sheet and a healthy cash position, we stand on a strong operational and financial foundation ready for growth. The sustained vigour in our sales and marketing activities instils confidence in our ability to achieve organic growth and meet expectations for the current financial year.

 

While macroeconomic and geopolitical uncertainties persist, we approach each challenge as an opportunity, engaging the collective talents of our team. The Board of Directors remains confident in the Group's prospects in the medium to long term. We are committed to capitalising on this Year's performance and actively seeking strategic avenues for growth in conjunction with our organic initiatives.

 

 

Tim Jackson

CHAIRMAN

 

CEO REPORT

 

 

BUSINESS REVIEW

 

With the global markets becoming more active, the marketing and sales activities have recommenced at an energetic pace. The recent introduction of the new portable product has broadened our scope of opportunity and bolstered the Group's ability to compete in international tenders.

 

The sales team's active participation in trade shows and Counter Explosive Ordnance (Counter EO) conventions and demonstrations has provided market experts and thought leaders' exposure to the benefits of the Group's latest product offerings and enhancements, which has directly led to an improved financial performance and sales to over 30 different countries.

 

We have adeptly managed the reduction in the industrial business supporting the catalyst market (associated with the internal combustion engine) and its transition of production to lower-cost countries. Our strategic measures have, to date, successfully mitigated the impact of this transition on our business demonstrating our resilience in the face of market shifts.

 

 

OUR STRATEGY

 

The Group's strategy focuses on the organic growth of current activities by expansion of the product range, and its target territories. The Group seeks to operate in profitable, niche security segments for which it can offer differentiated products that it offers to the market at good margins.

 

In industrial screening, we will continue to mitigate the reduction in the catalyst market related to the internal combustion engine and its impact on the Group revenue.

 

The Group possesses extensive and valuable expertise in establishing and maintaining market routes, particularly in the field of security and Counter EO. It aims to enhance these channels by incorporating new, in-house-developed products or by identifying organisations that can provide innovative technologies or products associated with the industry, thereby enriching the Group's product portfolio. The process of identifying and analysing organisations offering products or services aligned with the Group has already begun.

 

 

OUTLOOK

 

We expect the increased market activity observed this year to be maintained, and with heightened engagement at trade shows and conferences, we anticipate a strengthening opportunity pipeline. Expanding our product range is not only a safeguard for our market position but also provides access to opportunities that were previously unavailable with our historic product portfolio.

 

The Group is steadily building on its initial sales for the AXIS range X-ray systems, with a focus on showcasing this product prominently at upcoming exhibitions in the coming year. Sales of this product line are anticipated to experience growth in the upcoming financial year.

 

We will concentrate on our core expertise, specifically our portable X-ray products and associated software. This strategic focus is aimed at sustaining and expanding our market share, countering competition in this market. Our approach involves extending our range into markets featuring higher performance and higher value systems.

 

Recognising the diminishing prominence of internal combustion engines and the imperative shift towards achieving net-zero emissions, we acknowledge the necessity to pinpoint alternative sectors where our industrial inspection technology can offer a suitable and cost-effective solution, whilst minimising the impact of the decline in this revenue source. Our focus for success in this sector lies in aligning with replacement technologies for internal combustion engines which is a longer-term strategic priority.

 

Image Scan has successfully navigated through the challenges posed by this year's inflationary pressures, as well as the disruptions to supply chains and logistical difficulties. While the impact of supply chain disruptions is diminishing, there remains a concern regarding the supply of certain components that are beyond the control of the Group.

 

With our new organisational structure and reduced cost base, we believe we are well-positioned to sustain the momentum of this year's achievements. Our goal is to enhance the Group's profitability and leverage the advantages of the Group listing to strategically advance the business. Our focus is on executing deliberate actions that contribute to the strategic growth of the Group, moving beyond organic growth alone.

 

 

Vincent Deery

CHIEF EXECUTIVE OFFICER

 

CFO REPORT

 

KEY PERFORMANCE INDICATORS

 

 

2023

2022

2021

2020

2019

Order intake

£2.9m

£2.2m

£2.8m

£2.4m

£3.9m

Turnover

£3.0m

£2.0m

£2.9m

£3.5m

£2.4m

Gross margin

48%

54%

53%

49%

54%

Cash balance

£958k

£690k

£1,186k

£1,409k

£640k

Inventory Balance

£349k

£629k

£393k

£451k

£483k

 

 

FINANCIAL RESULTS

 

The Group had a much improved financial year, turning a pre-tax loss of £350k into a pre-tax profit of £0.1m. In addition bank balances increased by £268k to £958k (2022: £690k) putting us in a good position to continue to build the Group and its product portfolio.

 

As highlighted in the CEO Report, we saw renewed activity in the security market and this led to sales growth of 50%, increasing sales to £3.0m. This was driven by an increase in original equipment sales of 70% growth, including a good contribution from our most recently launched products. All regions saw sales growth, with the largest growth coming from Europe/Middle East and Africa.

 

A change in mix of products as well as inflationary pressures of component cost pushed gross margin down from 54% to 48% and an internal focus in the coming year will be on working with our suppliers to manage our component cost base. A strong focus by the team on the customer requirement has ensured that goods are received by our customers in a timely manner with very high standards of quality which has resulted in lower levels of spend on warranty.

 

In the Year, the Group applied for and won a number of grants towards our marketing and development activity, and we will continue to explore further funding opportunities. 

 

Alongside the restructure of the Board and Management team, driving down costs has been a successful focus for the Year, while enabling the Group to continue to invest in product development and marketing.

 

As well as the reported participation in trade shows, the Group has also increased the number of demonstration kits held and upgraded the current kits allowing the team to better tailor its demonstrations to the requirements of the customer. These investments were made while administration expenses were reduced by 5% from £1.42m to £1.35m.

 

This work alongside the tremendous efforts of the sales team have seen a return to profit of £0.1m (2022; loss £350k) which is a testament to the whole team.

 

Funds from R&D tax credits were down as the Government reduced the allowance from April 2023 but are still a good source of cashflow for the business.

 

In the Year, our focus on strategic inventory management proved highly successful, as we drove down stock levels. This achievement reflects our commitment to operational efficiency whilst still being able to ensure our continued ability to respond promptly to customer requests, contributing significantly to our overall success. Stock levels have fallen from £629k to £349k ensuring funds are not tied up unnecessarily while delivering in agreed timescales.

 

At the same time, bank balances have increased to £958k (2022: £690k) which is a net increase of £268k. Funds generated from operating activities were positive at £430k (2022: used £290k) some of which has been invested in the new product range with a combined spend net of grants of £309k (2022: £395k without grants).

 

Delivering the turn around and achieving a pre-tax profit of £0.1m could not have been achieved without the commitment and focus of the team at Image Scan and I would add my thanks to the whole team.

 

 

Sarah Atwell King

CHIEF FINANCIAL OFFICER

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the year ended 30 September 2023

 

Note

 

2023

£

 

2022

£

 

REVENUE

2,962,934

2,002,299

Cost of sales

(1,527,723)

(924,380)

 

 

Gross profit

1,435,211

1,077,919

 

 

Administrative expenses

(1,354,652)

(1,421,456)

Other Operating Income

14,934

-

 

 

OPERATING PROFIT/(LOSS)

95,493

(343,537)

 

Finance income

6,639

440

Interest payable and similar charges

(5,555)

(6,426)

 

 

PROFIT/(LOSS) BEFORE TAXATION

96,577

(349,523)

 

 

Taxation

27,362

77,998

 

 

 

PROFIT /(LOSS) AND TOTAL COMPREHENSIVE INCOME/(LOSS) FOR THE YEAR FROM CONTINUING OPERATIONS ATTRIBUTABLE TO THE EQUITY OWNERS OF THE PARENT COMPANY

 

2

 

123,939

 

 

(271,525)

 

 

 

 

 

 

 

 

Pence

Pence

Earnings/(loss) per share

 

Basic

0.09

(0.20)

Diluted

0.09

(0.20)

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 September 2023

 

 

2023

£

 

2022

£

NON-CURRENT ASSETS

Intangible assets

320,957

257,554

Property, plant and equipment

6,599

13,559

Right of use asset

153,678

193,053

 

 

 

 

481,234

464,166

 

 

 

CURRENT ASSETS

 

Inventories

348,753

628,903

Trade and other receivables

633,870

638,292

Cash and cash equivalents

958,465

689,543

 

 

1,941,088

1,956,738

 

 

 

TOTAL ASSETS

2,422,322

2,420,904

 

 

 

CURRENT LIABILITIES

 

Trade and other payables

712,455

793,459

Lease liability

37,625

37,625

Warranty provision

33,858

37,930

 

 

 

783,938

869,014

 

 

 

NON-CURRENT LIABILITIES

 

Lease liability

126,683

164,128

 

 

 

 

126,683

164,128

 

 

 

 

 

NET ASSETS

1,511,701

1,387,762

 

 

 

EQUITY

 

Share capital

1,368,546

1,368,546

Share premium account

8,332,910

8,332,910

Profit and loss account

(8,189,755)

(8,313,694)

 

 

 

TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS

1,511,701

1,387,762

 

 

 

 

 

 

STATEMENT OF CHANGES IN EQUITY

For the year ended 30 September 2023

 

Share capital

£

Share premium

£

Profit and loss account

£

 

Total

£

As at 1 October 2021

1,363,546

8,327,910

(8,042,169)

1,649,287

 

 

Shares issued in the year

5,000

5,000

-

10,000

Loss for the year and total comprehensive income for the year

-

-

(271,525)

(271,525)

 

 

 

 

As at 30 September 2022

1,368,546

8,332,910

(8,313,694)

1,387,762

Shares issued in the year

-

-

-

-

Profit for the year and total comprehensive loss for the year

-

-

123,939

123,939

 

 

 

 

 

As at 30 September 2023

1,368,546

8,332,910

(8,189,755)

1,511,701

 

 

 

 

 

 

CONSOLIDATED CASH FLOW STATEMENT

Year ended 30 September 2023

 

 

2023

£

 

2022

£

Cash flows from operating activities

 

 

 

Operating profit /(loss)

95,493

(343,537)

 

Adjustments for:

 

Amortisation of intangible assets

60,887

29,381

Depreciation

6,960

6,098

Amortisation of right of use asset

39,375

39,375

Decrease in impairment of inventories

(54,349)

(11,263)

Decrease/(increase) in inventories

334,499

(224,566)

(Increase)/decrease in trade and other receivables

(40,485)

132,441

(Decrease)/increase in trade and other payables

(81,004)

41,179

Decrease in warranty provisions

(4,072)

(7,710)

 

 

 

Cash generated from / (used in) operating activities

357,304

(338,602)

Corporation tax received

72,269

48,114

 

 

 

 

 

429,573

(290,488)

 

 

 

 

 

Cash flows from investing activities

 

Interest received

6,639

440

Purchase of intangibles

(124,290)

(177,345)

Purchase of property, plant and equipment

-

(1,862)

 

 

Net cash used in investing activities

(117,651)

(178,767)

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

Lease payments (capital and interest)

(43,000)

(37,625)

Proceeds from issue of share capital

-

10,000

 

 

 

Net cash used in financing activities

 

 

(43,000)

(27,625)

 

 

 

Net INCREASE/(DECREASE) in cash and cash equivalents

268,922

(496,880)

Cash and cash equivalents at beginning of year

 

 

689,543

1,186,423

 

 

 

 

 

Cash and cash equivalents at end of year

 

 

958,465

689,543

 

 

 

 

 

Notes to the preliminary statement

1. Basis of preparation

While the financial information included in this annual financial results announcement has been prepared in accordance with the recognition and measurement principles of UK adopted international accounting standards, this announcement does not contain sufficient information to comply therewith.The financial information set out above does not constitute the Group's statutory accounts for the years ended 30 September 2023 or 30 September 2022 but is derived from those accounts. Statutory accounts for 2022 have been delivered to the Registrar of Companies, and those for 2023 will be delivered following the Company's Annual General Meeting. The auditors have reported on those accounts; their reports were unqualified and did not contain statements under Section 498 of the Companies Act 2006.

 

2. Earnings per share

The diluted earnings per share is calculated by adjusting the weighted average number of ordinary shares in issue on the assumption of conversion of dilutive potential ordinary shares. The Company's dilutive potential ordinary shares are shares issued under the Company's Enterprise Management Incentive ('EMI') scheme and options issued under the Company's Unapproved scheme. Where the Company is reporting losses, the impact of share options is considered anti-dilutive. Where the Company is reporting profits, share options could potentially dilute basic earnings per share in the future but are only included in the calculation of diluted earnings per share when the exercise price of the share options is below the average share price in the year.

 

 

2023

£

2022

£

Profit/(loss) for the year

123,939

(271,525)

 

 

Weighted average number of ordinary shares in issue

136,854,577

136,753,207

Number of diluted shares

136,854,577

136.753.207

 

 

Basic profit/(loss) per share

0.09p

(0.20)p

Diluted profit/(loss) per share

0.09p

(0.20)p

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR NKDBDCBDDNBD
Date   Source Headline
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM
22nd Feb 20217:00 amRNSTrading Statement
15th Feb 202111:33 amRNSMello presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.